Skip to main content

Focusing on inflammation in the treatment of atherosclerosis.

Publication ,  Journal Article
Call, JT; Deliargyris, EN; Newby, LK
Published in: Cardiol Rev
2004

Modern-day treatment of atherosclerosis has arisen primarily from an understanding of the epidemiology of the disease rather than its pathophysiology, in that risk factors have traditionally been targeted. Now that the pivotal role of inflammation in the process of atherosclerosis is recognized, it is noteworthy to evaluate the effect of modern therapies on this facet of the disease. This article first reviews the role of inflammation in the pathophysiology of atherosclerosis, and then explores potential mechanisms by which modern-day therapies can modify this inflammation.

Duke Scholars

Published In

Cardiol Rev

DOI

ISSN

1061-5377

Publication Date

2004

Volume

12

Issue

4

Start / End Page

194 / 200

Location

United States

Related Subject Headings

  • Tunica Intima
  • Risk Factors
  • Pyrimidines
  • Inflammation
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Exercise
  • Evidence-Based Medicine
  • Estrogen Replacement Therapy
  • Endothelium, Vascular
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Call, J. T., Deliargyris, E. N., & Newby, L. K. (2004). Focusing on inflammation in the treatment of atherosclerosis. Cardiol Rev, 12(4), 194–200. https://doi.org/10.1097/01.crd.0000111822.34362.71
Call, Jason T., Efthymios N. Deliargyris, and L Kristin Newby. “Focusing on inflammation in the treatment of atherosclerosis.Cardiol Rev 12, no. 4 (2004): 194–200. https://doi.org/10.1097/01.crd.0000111822.34362.71.
Call JT, Deliargyris EN, Newby LK. Focusing on inflammation in the treatment of atherosclerosis. Cardiol Rev. 2004;12(4):194–200.
Call, Jason T., et al. “Focusing on inflammation in the treatment of atherosclerosis.Cardiol Rev, vol. 12, no. 4, 2004, pp. 194–200. Pubmed, doi:10.1097/01.crd.0000111822.34362.71.
Call JT, Deliargyris EN, Newby LK. Focusing on inflammation in the treatment of atherosclerosis. Cardiol Rev. 2004;12(4):194–200.

Published In

Cardiol Rev

DOI

ISSN

1061-5377

Publication Date

2004

Volume

12

Issue

4

Start / End Page

194 / 200

Location

United States

Related Subject Headings

  • Tunica Intima
  • Risk Factors
  • Pyrimidines
  • Inflammation
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Exercise
  • Evidence-Based Medicine
  • Estrogen Replacement Therapy
  • Endothelium, Vascular